Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
November-2020 Volume 20 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
November-2020 Volume 20 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Y‑box binding protein 1 acts as a negative regulator of stearoyl CoA desaturase 1 in clear cell renal cell carcinoma

  • Authors:
    • Eric Jeffords
    • Samuel Freeman
    • Breanna Cole
    • Kate Root
    • Thierry Chekouo
    • Richard G. Melvin
    • Lynne Bemis
    • Glenn E. Simmons Jr
  • View Affiliations / Copyright

    Affiliations: Department of Biology, The College of St. Scholastica, Duluth, MN 55811, USA, Department of Biomedical Sciences, University of Minnesota Medical School, Duluth, MN 55812, USA, Department of Mathematics and Statistics, University of Calgary, Calgary, AB T2N1N4, Canada
    Copyright: © Jeffords et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 165
    |
    Published online on: August 26, 2020
       https://doi.org/10.3892/ol.2020.12026
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Y‑box binding protein 1 (YB‑1) is a regulatory protein associated with oncogenesis and poor prognosis in patients with cancer. In the cell, YB‑1 functions as a DNA and RNA binding protein that promotes or suppresses expression of target genes. The cancer‑promoting activity of YB‑1 is mediated through its activation of oncogenes and repression of tumor suppressor genes. Lipogenic enzyme stearoyl‑CoA desaturase (SCD1) drives the production of endogenous monounsaturated fatty acids (MUFAs) in cells and protects against toxic buildup of saturated fatty acids. Clear cell renal cell carcinoma (ccRCC) is often characterized by aberrantly high SCD1 expression and cytosolic accumulation of unsaturated fatty acids. In the present study, a proteomics screen of cells treated with inhibitors of SCD1 supported a potential relationship between YB‑1 and SCD1. It was revealed that the presence of MUFAs led to increased protein synthesis and increased expression of high molecular weight forms of YB‑1 in ccRCC cells, but not in non‑tumorigenic cells. Ectopic expression of YB‑1 led to decreased expression levels of SCD1 protein and mRNA in ccRCC cell lines. Conversely, targeted knockdown of YB‑1 increased SCD1 mRNA abundance. Analysis of ccRCC patient data from the Cancer Proteome Atlas database showed YB‑1 expression was negatively associated with survival, whereas SCD1 was associated with improved survival. These data suggested an antagonistic relationship between YB‑1 and SCD1 that may influence survival of patients with ccRCC.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

View References

1 

Noone AM, Cronin KA, Altekruse SF, Howlader N, Lewis DR, Petkov VI and Penberthy L: Cancer incidence and survival trends by subtype using data from the surveillance epidemiology and end results program, 1992–2013. Cancer Epidemiol Biomarkers Prev. 26:632–641. 2017. View Article : Google Scholar : PubMed/NCBI

2 

Wang H, Zhang Y, Lu Y, Song J, Huang M, Zhang J and Huang Y: The role of stearoyl-coenzyme A desaturase 1 in clear cell renal cell carcinoma. Tumour Biol. 37:479–489. 2016. View Article : Google Scholar : PubMed/NCBI

3 

Zaidi N, Lupien L, Kuemmerle NB, Kinlaw WB, Swinnen JV and Smans K: Lipogenesis and lipolysis: The pathways exploited by the cancer cells to acquire fatty acids. Prog Lipid Res. 52:585–589. 2013. View Article : Google Scholar : PubMed/NCBI

4 

Ameer F, Scandiuzzi L, Hasnain S, Kalbacher H and Zaidi N: De novo lipogenesis in health and disease. Metabolism. 63:895–902. 2014. View Article : Google Scholar : PubMed/NCBI

5 

Vriens K, Christen S, Parik S, Broekaert D, Yoshinaga K, Talebi A, Dehairs J, Escalona-Noguero C, Schmieder R, Cornfield T, et al: Evidence for an alternative fatty acid desaturation pathway increasing cancer plasticity. Nature. 566:403–406. 2019. View Article : Google Scholar : PubMed/NCBI

6 

Iwamoto H, Abe M, Yang Y, Cui D, Seki T, Nakamura M, Hosaka K, Lim S, Wu J, He X, et al: Cancer lipid metabolism confers antiangiogenic drug resistance. Cell Metab. 28:104–117. 2018. View Article : Google Scholar : PubMed/NCBI

7 

Ntambi JM: Regulation of stearoyl-CoA desaturase by polyunsaturated fatty acids and cholesterol. J Lipid Res. 40:1549–1558. 1999.PubMed/NCBI

8 

Falvella FS, Pascale RM, Gariboldi M, Manenti G, De Miglio MR, Simile MM, Dragani TA and Feo F: Stearoyl-CoA desaturase 1 (Scd1) gene overexpression is associated with genetic predisposition to hepatocarcinogenesis in mice and rats. Carcinogenesis. 23:1933–1936. 2002. View Article : Google Scholar : PubMed/NCBI

9 

von Roemeling CA, Marlow LA, Pinkerton AB, Crist A, Miller J, Tun HW, Smallridge RC and Copland JA: Aberrant lipid metabolism in anaplastic thyroid carcinoma reveals stearoyl CoA desaturase 1 as a novel therapeutic target. J Clin Endocrinol Metab. 100:E697–E709. 2015. View Article : Google Scholar : PubMed/NCBI

10 

Kim H, Rodriguez-Navas C, Kollipara RK, Kapur P, Pedrosa I, Brugarolas J, Kittler R and Ye J: Unsaturated fatty acids stimulate tumor growth through stabilization of beta-catenin. Cell Rep. 13:495–503. 2015. View Article : Google Scholar : PubMed/NCBI

11 

Soto-Guzman A, Navarro-Tito N, Castro-Sanchez L, Martinez-Orozco R and Salazar EP: Oleic acid promotes MMP-9 secretion and invasion in breast cancer cells. Clin Exp Metastasis. 27:505–515. 2010. View Article : Google Scholar : PubMed/NCBI

12 

von Roemeling CA and Copland JA: Targeting lipid metabolism for the treatment of anaplastic thyroid carcinoma. Expert Opin Ther Targets. 20:159–166. 2016. View Article : Google Scholar : PubMed/NCBI

13 

Igal RA: Stearoyl-CoA desaturase-1: A novel key player in the mechanisms of cell proliferation, programmed cell death and transformation to cancer. Carcinogenesis. 31:1509–1515. 2010. View Article : Google Scholar : PubMed/NCBI

14 

Roongta UV, Pabalan JG, Wang X, Ryseck RP, Fargnoli J, Henley BJ, Yang WP, Zhu J, Madireddi MT, Lawrence RM, et al: Cancer cell dependence on unsaturated fatty acids implicates stearoyl-CoA desaturase as a target for cancer therapy. Mol Cancer Res. 9:1551–1561. 2011. View Article : Google Scholar : PubMed/NCBI

15 

Tosi MR, Fini G, Tinti A, Reggiani A and Tugnoli V: Molecular characterization of human healthy and neoplastic cerebral and renal tissues by in vitro (1)H NMR spectroscopy (review). Int J Mol Med. 9:299–310. 2002.PubMed/NCBI

16 

Tugnoli V, Reggiani A, Beghelli R, Tomaselli V, Trinchero A and Tosi MR: Magnetic resonance spectroscopy and high performance liquid chromatography of neoplastic human renal tissues. Anticancer Res. 23:1541–1548. 2003.PubMed/NCBI

17 

Tugnoli V, Bottura G, Fini G, Reggiani A, Tinti A, Trinchero A and Tosi MR: 1H-NMR and 13C-NMR lipid profiles of human renal tissues. Biopolymers. 72:86–95. 2003. View Article : Google Scholar : PubMed/NCBI

18 

Mukherjee A, Kenny HA and Lengyel E: Unsaturated fatty acids maintain cancer cell stemness. Cell Stem Cell. 20:291–292. 2017. View Article : Google Scholar : PubMed/NCBI

19 

Li J, Condello S, Thomes-Pepin J, Ma X, Xia Y, Hurley TD, Matei D and Cheng JX: Lipid desaturation is a metabolic marker and therapeutic target of ovarian cancer stem cells. Cell Stem Cell. 20:303–314.e5. 2017. View Article : Google Scholar : PubMed/NCBI

20 

Kawahara I, Mori T, Goto K, Fujii K, Ohmori H, Kishi S, Fujiwara-Tani R and Kuniyasu H: Fatty acids induce stemness in the stromal cells of a CT26 mouse tumor model. Pathobiology. 84:237–242. 2017. View Article : Google Scholar : PubMed/NCBI

21 

Parrales A, Ranjan A and Iwakuma T: Unsaturated fatty acids regulate stemness of ovarian cancer cells through NF-κB. Stem Cell Investig. 4:492017. View Article : Google Scholar : PubMed/NCBI

22 

Del Río LF, Gutiérrez-Casado E, Varela-López A and Villalba JM: Olive oil and the hallmarks of aging. Molecules. 21:1632016. View Article : Google Scholar : PubMed/NCBI

23 

Imanikia S, Sheng M, Castro C, Griffin JL and Taylor RC: XBP-1 remodels lipid metabolism to extend longevity. Cell Rep. 28:581–589.e4. 2019. View Article : Google Scholar : PubMed/NCBI

24 

Giacosa A, Barale R, Bavaresco L, Faliva MA, Gerbi V, La Vecchia C, Negri E, Opizzi A, Perna S, Pezzotti M and Rondanelli M: Mediterranean way of drinking and longevity. Crit Rev Food Sci Nutr. 56:635–640. 2016. View Article : Google Scholar : PubMed/NCBI

25 

Goudeau J, Bellemin S, Toselli-Mollereau E, Shamalnasab M, Chen Y and Aguilaniu H: Fatty acid desaturation links germ cell loss to longevity through NHR-80/HNF4 in C. elegans. PLoS Biol. 9:e10005992011. View Article : Google Scholar : PubMed/NCBI

26 

Schaffer JE: Lipotoxicity: When tissues overeat. Curr Opin Lipidol. 14:281–287. 2003. View Article : Google Scholar : PubMed/NCBI

27 

Schaffer JE: Lipotoxicity: Many roads to cell dysfunction and cell death: Introduction to a thematic review series. J Lipid Res. 57:1327–1328. 2016. View Article : Google Scholar : PubMed/NCBI

28 

Noto A, Raffa S, De Vitis C, Roscilli G, Malpicci D, Coluccia P, Di Napoli A, Ricci A, Giovagnoli MR, Aurisicchio L, et al: Stearoyl-CoA desaturase-1 is a key factor for lung cancer-initiating cells. Cell Death Dis. 4:e9472013. View Article : Google Scholar : PubMed/NCBI

29 

Mason P, Liang B, Li L, Fremgen T, Murphy E, Quinn A, Madden SL, Biemann HP, Wang B, Cohen A, et al: SCD1 inhibition causes cancer cell death by depleting mono-unsaturated fatty acids. PLoS One. 7:e338232012. View Article : Google Scholar : PubMed/NCBI

30 

Hess D, Chisholm JW and Igal RA: Inhibition of stearoylCoA desaturase activity blocks cell cycle progression and induces programmed cell death in lung cancer cells. PLoS One. 5:e113942010. View Article : Google Scholar : PubMed/NCBI

31 

Kleene KC: Y-box proteins combine versatile cold shock domains and arginine-rich motifs (ARMs) for pleiotropic functions in RNA biology. Biochem J. 475:2769–2784. 2018. View Article : Google Scholar : PubMed/NCBI

32 

Lyons SM, Achorn C, Kedersha NL, Anderson PJ and Ivanov P: YB-1 regulates tiRNA-induced stress granule formation but not translational repression. Nucleic Acids Res. 44:6949–6960. 2016. View Article : Google Scholar : PubMed/NCBI

33 

Somasekharan SP, El-Naggar A, Leprivier G, Cheng H, Hajee S, Grunewald TGP, Zhang F, Ng T, Delattre O, Evdokimova V, et al: YB-1 regulates stress granule formation and tumor progression by translationally activating G3BP1. J Cell Biol. 208:913–929. 2015. View Article : Google Scholar : PubMed/NCBI

34 

Willis WL, Hariharan S, David JJ and Strauch AR: Transglutaminase-2 mediates calcium-regulated crosslinking of the Y-Box 1 (YB-1) translation-regulatory protein in TGFβ1-activated myofibroblasts. J Cell Biochem. 114:2753–2769. 2013. View Article : Google Scholar : PubMed/NCBI

35 

Zhang A, Liu X, Cogan JG, Fuerst MD, Polikandriotis JA, Kelm RJ Jr and Strauch AR: YB-1 coordinates vascular smooth muscle α-actin gene activation by transforming growth factor β1 and thrombin during differentiation of human pulmonary myofibroblasts. Mol Biol Cell. 16:4931–4940. 2005. View Article : Google Scholar : PubMed/NCBI

36 

Miao X, Wu Y, Wang Y, Zhu X, Yin H, He Y, Li C, Liu Y, Lu X, Chen Y, et al: Y-box-binding protein-1 (YB-1) promotes cell proliferation, adhesion and drug resistance in diffuse large B-cell lymphoma. Exp Cell Res. 346:157–166. 2016. View Article : Google Scholar : PubMed/NCBI

37 

Heumann A, Kaya Ö, Burdelski C, Hube-Magg C, Kluth M, Lang DS, Simon R, Beyer B, Thederan I, Sauter G, et al: Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer. Sci Rep. 7:20562017. View Article : Google Scholar : PubMed/NCBI

38 

Ha B, Lee EB, Cui J, Kim Y and Jang HH: YB-1 overexpression promotes a TGF-β1-induced epithelial-mesenchymal transition via Akt activation. Biochem Biophys Res Commun. 458:347–351. 2015. View Article : Google Scholar : PubMed/NCBI

39 

Wu SL, Fu X, Huang J, Jia TT, Zong FY, Mu SR, Zhu H, Yan Y, Qiu S, Wu Q, et al: Genome-wide analysis of YB-1-RNA interactions reveals a novel role of YB-1 in miRNA processing in glioblastoma multiforme. Nucleic Acids Res. 43:8516–8528. 2015. View Article : Google Scholar : PubMed/NCBI

40 

Wei WJ, Mu SR, Heiner M, Fu X, Cao LJ, Gong XF, Bindereif A and Hui J: YB-1 binds to CAUC motifs and stimulates exon inclusion by enhancing the recruitment of U2AF to weak polypyrimidine tracts. Nucleic Acids Res. 40:8622–8636. 2012. View Article : Google Scholar : PubMed/NCBI

41 

Dolfini D and Mantovani R: Targeting the Y/CCAAT box in cancer: YB-1 (YBX1) or NF-Y. Cell Death Differ. 20:676–685. 2013. View Article : Google Scholar : PubMed/NCBI

42 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

43 

Shurtleff MJ, Temoche-Diaz MM, Karfilis KV, Ri S and Schekman R: Y-box protein 1 is required to sort microRNAs into exosomes in cells and in a cell-free reaction. Elife. 5:e192762016. View Article : Google Scholar : PubMed/NCBI

44 

Peter A, Weigert C, Staiger H, Rittig K, Cegan A, Lutz P, Machicao F, Häring HU and Schleicher E: Induction of stearoyl-CoA desaturase protects human arterial endothelial cells against lipotoxicity. Am J Physiol Endocrinol Metab. 295:E339–E349. 2008. View Article : Google Scholar : PubMed/NCBI

45 

Yuan Z, Shin J, Wilson A, Goel S, Ling YH, Ahmed N, Dopeso H, Jhawer M, Nasser S, Montagna C, et al: An A13 repeat within the 3-untranslated region of epidermal growth factor receptor (EGFR) is frequently mutated in microsatellite instability colon cancers and is associated with increased EGFR expression. Cancer Res. 69:7811–7818. 2009. View Article : Google Scholar : PubMed/NCBI

46 

Khan A, Fornes O, Stigliani A, Gheorghe M, Castro-Mondragon JA, van der Lee R, Bessy A, Chèneby J, Kulkarni SR, Tan G, et al: JASPAR 2018: Update of the open-access database of transcription factor binding profiles and its web framework. Nucleic Acids Res. 46:D260–D266. 2018. View Article : Google Scholar : PubMed/NCBI

47 

Li J, Lu Y, Akbani R, Ju Z, Roebuck PL, Liu W, Yang JY, Broom BM, Verhaak RGW, Kane DW, et al: TCPA: A resource for cancer functional proteomics data. Nat Methods. 10:1046–1047. 2013. View Article : Google Scholar : PubMed/NCBI

48 

Pisanu ME, Noto A, De Vitis C, Morrone S, Scognamiglio G, Botti G, Venuta F, Diso D, Jakopin Z, Padula F, et al: Blockade of Stearoyl-CoA-desaturase 1 activity reverts resistance to cisplatin in lung cancer stem cells. Cancer Lett. 406:93–104. 2017. View Article : Google Scholar : PubMed/NCBI

49 

Horikawa M, Nomura T, Hashimoto T and Sakamoto K: Elongation and desaturation of fatty acids are critical in growth, lipid metabolism and ontogeny of caenorhabditis elegans. J Biochem. 144:149–158. 2008. View Article : Google Scholar : PubMed/NCBI

50 

von Roemeling CA, Marlow LA, Wei JJ, Cooper SJ, Caulfield TR, Wu K, Tan WW, Tun HW and Copland JA: Stearoyl-CoA desaturase 1 is a novel molecular therapeutic target for clear cell renal cell carcinoma. Clin Cancer Res. 19:2368–2380. 2013. View Article : Google Scholar : PubMed/NCBI

51 

Zhang H, Li H, Ho N, Li D and Li S: Scd1 plays a tumor-suppressive role in survival of leukemia stem cells and the development of chronic myeloid leukemia. Mol Cell Biol. 32:1776–1787. 2012. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Jeffords E, Freeman S, Cole B, Root K, Chekouo T, Melvin RG, Bemis L and Simmons Jr GE: Y‑box binding protein 1 acts as a negative regulator of stearoyl CoA desaturase 1 in clear cell renal cell carcinoma. Oncol Lett 20: 165, 2020.
APA
Jeffords, E., Freeman, S., Cole, B., Root, K., Chekouo, T., Melvin, R.G. ... Simmons Jr, G.E. (2020). Y‑box binding protein 1 acts as a negative regulator of stearoyl CoA desaturase 1 in clear cell renal cell carcinoma. Oncology Letters, 20, 165. https://doi.org/10.3892/ol.2020.12026
MLA
Jeffords, E., Freeman, S., Cole, B., Root, K., Chekouo, T., Melvin, R. G., Bemis, L., Simmons Jr, G. E."Y‑box binding protein 1 acts as a negative regulator of stearoyl CoA desaturase 1 in clear cell renal cell carcinoma". Oncology Letters 20.5 (2020): 165.
Chicago
Jeffords, E., Freeman, S., Cole, B., Root, K., Chekouo, T., Melvin, R. G., Bemis, L., Simmons Jr, G. E."Y‑box binding protein 1 acts as a negative regulator of stearoyl CoA desaturase 1 in clear cell renal cell carcinoma". Oncology Letters 20, no. 5 (2020): 165. https://doi.org/10.3892/ol.2020.12026
Copy and paste a formatted citation
x
Spandidos Publications style
Jeffords E, Freeman S, Cole B, Root K, Chekouo T, Melvin RG, Bemis L and Simmons Jr GE: Y‑box binding protein 1 acts as a negative regulator of stearoyl CoA desaturase 1 in clear cell renal cell carcinoma. Oncol Lett 20: 165, 2020.
APA
Jeffords, E., Freeman, S., Cole, B., Root, K., Chekouo, T., Melvin, R.G. ... Simmons Jr, G.E. (2020). Y‑box binding protein 1 acts as a negative regulator of stearoyl CoA desaturase 1 in clear cell renal cell carcinoma. Oncology Letters, 20, 165. https://doi.org/10.3892/ol.2020.12026
MLA
Jeffords, E., Freeman, S., Cole, B., Root, K., Chekouo, T., Melvin, R. G., Bemis, L., Simmons Jr, G. E."Y‑box binding protein 1 acts as a negative regulator of stearoyl CoA desaturase 1 in clear cell renal cell carcinoma". Oncology Letters 20.5 (2020): 165.
Chicago
Jeffords, E., Freeman, S., Cole, B., Root, K., Chekouo, T., Melvin, R. G., Bemis, L., Simmons Jr, G. E."Y‑box binding protein 1 acts as a negative regulator of stearoyl CoA desaturase 1 in clear cell renal cell carcinoma". Oncology Letters 20, no. 5 (2020): 165. https://doi.org/10.3892/ol.2020.12026
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team